Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 6/20 | 0.78 |
| ▸ | MEN1 | O00255 | 1/20 | 0.67 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.67 |
| ▸ | RAB9A | P51151 | 5/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.59 |
| ▸ | MAPT | P10636 | 3/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | DRD2 | P14416 | 1/20 | 0.41 |
| ▸ | DRD4 | P21917 | 1/20 | 0.41 |
| ▸ | DRD3 | P35462 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1198046 | 1.00 | NPC1 (0.78) | NPC1MEN1KMT2ARAB9ASMN1; SMN2 | |
| SCHEMBL27787638 | 1.00 | NPC1 (0.78) | NPC1MEN1KMT2ARAB9ASMN1; SMN2 | |
| SCHEMBL14352200 | 0.88 | NPC1 (1.00) | NPC1MEN1KMT2ARAB9ASMN1; SMN2 | |
| SCHEMBL30523534 | 0.88 | NPC1 (1.00) | NPC1MEN1KMT2ARAB9ASMN1; SMN2 | |
| SCHEMBL1465721 | 0.88 | NPC1 (1.00) | NPC1MEN1KMT2ARAB9ASMN1; SMN2 | |
| SCHEMBL1465722 | 0.88 | NPC1 (1.00) | NPC1MEN1KMT2ARAB9ASMN1; SMN2 | |
| SCHEMBL23850457 | 0.86 | NPC1 (0.59) | NPC1MEN1KMT2ARAB9ASMN1; SMN2 | |
| SCHEMBL8789931 | 0.84 | MEN1 (0.69) | NPC1MEN1KMT2ARAB9ASMN1; SMN2 | |
| SCHEMBL9398141 | 0.84 | MEN1 (0.69) | NPC1MEN1KMT2ARAB9ASMN1; SMN2 | |
| SCHEMBL19010013 | 0.84 | NPC1 (0.74) | NPC1MEN1KMT2ARAB9ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117123268-A | Acenaphthene imidazole nitrogen heterocyclic carbene chiral oxazoline ring palladium catalyst, preparation method and application thereof | 南京林业大学 | 2023-11-28 | — | — | CN | disclosed |
| EP-2476664-B1 | ZINC CLUSTER | TAKASAGO PERFUMERY CO LTD (JP) | 2015-03-04 | — | — | EP | disclosed |
| US-8552204-B2 | Zinc cluster | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2013-10-08 | — | — | US | disclosed |
| EP-1958940-B1 | CONDENSATION REACTION BY METAL CATALYST | TAKASAGO PERFUMERY CO LTD (JP) | 2013-06-26 | — | — | EP | disclosed |
| EP-1958940-B1 | CONDENSATION REACTION BY METAL CATALYST | TAKASAGO PERFUMERY CO LTD (JP) | 2013-06-26 | — | — | EP | disclosed |
| EP-2476664-A1 | ZINC CLUSTER | Takasago International Corporation (JP) | 2012-07-18 | — | — | EP | disclosed |
| US-20120172601-A1 | ZINC CLUSTER | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2012-07-05 | — | — | US | disclosed |
| US-20110098479-A1 | CONDENSATION REACTION BY METAL CATALYST | MASHIMA KAZUSHI | 2011-04-28 | — | — | US | disclosed |
| US-20110098479-A1 | CONDENSATION REACTION BY METAL CATALYST | MASHIMA KAZUSHI | 2011-04-28 | — | — | US | disclosed |
| US-20110098479-A1 | CONDENSATION REACTION BY METAL CATALYST | MASHIMA KAZUSHI | 2011-04-28 | — | — | US | disclosed |
| US-7888513-B2 | Condensation reaction by metal catalyst | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2011-02-15 | — | — | US | disclosed |
| US-7888513-B2 | Condensation reaction by metal catalyst | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2011-02-15 | — | — | US | disclosed |
| US-7888513-B2 | Condensation reaction by metal catalyst | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2011-02-15 | — | — | US | disclosed |
| US-20090198070-A1 | Condensation Reaction by Metal Catalyst | OSAKA UNIVERSITY (JP) | 2009-08-06 | — | — | US | disclosed |
| US-20090198070-A1 | Condensation Reaction by Metal Catalyst | OSAKA UNIVERSITY (JP) | 2009-08-06 | — | — | US | disclosed |
| US-20090198070-A1 | Condensation Reaction by Metal Catalyst | OSAKA UNIVERSITY (JP) | 2009-08-06 | — | — | US | disclosed |
| EP-1958940-A1 | CONDENSATION REACTION BY METAL CATALYST | Takasago International Corporation (JP) | 2008-08-20 | — | — | EP | disclosed |
| EP-1958940-A1 | CONDENSATION REACTION BY METAL CATALYST | Takasago International Corporation (JP) | 2008-08-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110098479-A1 | CONDENSATION REACTION BY METAL CATALYST | C9, CBR3, C1R | NPC1 3683/4885MEN1 120/4885KMT2A 1055/4885 |
| US-20090198070-A1 | Condensation Reaction by Metal Catalyst | C9, CBR3, C1R | NPC1 3683/4885MEN1 120/4885KMT2A 1055/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.